Autopsy report · NCT02490098
Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes
Cause of deathFunding or business
“Funding terminated”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Institut de Recherches Cliniques de Montreal
- Sponsor type
- University, hospital or other
- Conditions
- Type 1 Diabetes
- Interventions
- 6-day intervention with sensor-augmented pump therapy; 6-day intervention with single-hormone closed-loop strategy; 6-day intervention with dual-hormone closed-loop strategy; Insulin; Glucagon; Continuous Glucose Monitoring System Enlite sensor®, Medtronic
- Participants
- 0
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
“Funding was terminated” - Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
“Funding terminated by funding source.” - Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
“Souces of funding have been terminated” - Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
“Terminated due to insufficient funding” - Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
“Terminated due to loss of funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.